InvestorsHub Logo
Followers 3
Posts 283
Boards Moderated 0
Alias Born 09/28/2009

Re: None

Tuesday, 01/08/2019 10:38:11 AM

Tuesday, January 08, 2019 10:38:11 AM

Post# of 140477
For those of us that have been here for a couple of years have witnessed and felt the painful financing of a Canadian medical R&D technology play. Eventually at some point there is typically the "turnaround" date that is very difficult to predict. Afterwards, you either finance from exercise of the cheap warrants that you had to include as a deal sweetner or you finance at a much higher premium to the sp. In this case and I have said it before in my previous posts, the company need not go to the market anymore as they will have more than enough funds from the warrants series F-G-H-I to fill whats left to finance.